Cholesterol inhibition, cancer, and coronary heart disease

Mark R. Goldstein; Stephen B. Kritchevsky; Michael Goggins

doi:10.1016/0140-6736(92)90461-B

Cholesterol inhibition, cancer, and coronary heart disease

Mark R. Goldstein, Stephen B. Kritchevsky, Michael Goggins

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	127-128
Number of pages	2
Journal	The Lancet
Volume	340
Issue number	8811
DOIs	https://doi.org/10.1016/0140-6736(92)90461-B
State	Published - Jul 11 1992
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/0140-6736(92)90461-B

Cite this

@article{efe4e1812dc04f1a91ba586da2650ab9,

title = "Cholesterol inhibition, cancer, and coronary heart disease",

author = "Goldstein, {Mark R.} and Kritchevsky, {Stephen B.} and Michael Goggins",

year = "1992",

month = jul,

day = "11",

doi = "10.1016/0140-6736(92)90461-B",

language = "English (US)",

volume = "340",

pages = "127--128",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "8811",

}

TY - JOUR

T1 - Cholesterol inhibition, cancer, and coronary heart disease

AU - Goldstein, Mark R.

AU - Kritchevsky, Stephen B.

AU - Goggins, Michael

PY - 1992/7/11

Y1 - 1992/7/11

UR - http://www.scopus.com/inward/record.url?scp=0026659618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026659618&partnerID=8YFLogxK

U2 - 10.1016/0140-6736(92)90461-B

DO - 10.1016/0140-6736(92)90461-B

M3 - Letter

C2 - 1352008

AN - SCOPUS:0026659618

SN - 0140-6736

VL - 340

SP - 127

EP - 128

JO - The Lancet

JF - The Lancet

IS - 8811

ER -

Cholesterol inhibition, cancer, and coronary heart disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this